Thymidine substitution by 5-bromodeoxiuridine (BUDR) in metaphase chromosomes
dc.contributor.author | Venter P.A. | |
dc.date.accessioned | 2011-05-15T16:16:49Z | |
dc.date.available | 2011-05-15T16:16:49Z | |
dc.date.issued | 1979 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.citation | Journal of Anatomy | |
dc.identifier.citation | 129 | |
dc.identifier.citation | 4 | |
dc.identifier.issn | 00218782 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13952 | |
dc.subject | broxuridine | |
dc.subject | dna synthesis | |
dc.subject | drug absorption | |
dc.subject | heredity | |
dc.subject | in vitro study | |
dc.subject | karyotype 46,XY female | |
dc.subject | klinefelter syndrome | |
dc.subject | major clinical study | |
dc.subject | metaphase | |
dc.subject | X chromosome | |
dc.subject | XX male | |
dc.title | Thymidine substitution by 5-bromodeoxiuridine (BUDR) in metaphase chromosomes |